RT Journal Article
SR Electronic
T1 Estimating bone marrow adiposity from head MRI and identifying its genetic architecture
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.19.22278950
DO 10.1101/2022.08.19.22278950
A1 Kaufmann, Tobias
A1 Bjørnstad, Pål Marius
A1 Falck, Martin
A1 Nerland, Stener
A1 O’Connell, Kevin
A1 Frei, Oleksandr
A1 Andreassen, Ole A.
A1 Westlye, Lars T.
A1 Djurovic, Srdjan
A1 Hughes, Timothy
YR 2024
UL http://medrxiv.org/content/early/2024/08/22/2022.08.19.22278950.abstract
AB Bone marrow adiposity changes radically through the lifespan, but this phenomenon is poorly characterised and understood in humans. Large datasets of magnetic resonance imaging (MRI) scans of the head have been collected to study the human brain, but also contain unexploited information about other organs. We developed an artificial neural network that localises calvarial bone marrow in T1-weighted MRI head scans, enabling us to study its composition in several large MRI datasets, and to model sex-dimorphic age trajectories, including the effect of menopause. We revealed high heritability in single-nucleotide polymorphism and twin data, and identified 41 genetic loci significantly associated with the trait, including six sex-specific loci. Integrating mapped genes with existing bone marrow single-cell RNA-sequencing data revealed patterns of adipogenic lineage differentiation and lipid loading. Finally, we identified significant genetic correlations with several human traits, including cognitive ability and Parkinson’s disease, which is intriguing in light of the recently discovered channels that link calvarial bone marrow to the meninges.Competing Interest StatementOAA has received speaker’s honorarium from Lundbeck and Sunovion, and is a consultant to HealthLytix. Other authors report no competing interests.Funding StatementWe acknowledge the following funding sources. TK: RCN (276082, 323961). TH: RCN (295679). OAA: RCN (223273) and EU’s H2020 RIA (grant 847776). LTW: EU H2020 ERC StG (Grant 802998); RCN (223273, 249795, 248238, 286838); the South-Eastern Norway Regional Health Authority (2014097, 2015044, 2015073, 2016083, 2018037, 2018076. 2019101). We would like to thank everyone involved with the collection and sharing of imaging and genetics data used in this study. Analysis was performed on the TSD computer facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) and on resources provided by UNINETT Sigma2 - the National Infrastructure for High Performance Computing and Data Storage in Norway.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We obtained data from various cohorts where each data collection has been approved by the respective ethics boards and all participants gave informed written consent. Specifically, the National Health Service National Research Ethics Service gave ethical approval to the UK Biobank (ref. 11/NW/0382), the Washington University institutional review board gave ethical approval to the Human Connectome Project, and the local ethics committee at Hangzhou Normal University gave ethical approval to the HNU study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available in the main text or the supplementary materials. This research has been conducted using the UK Biobank Resource (78) (access code 27412), the Human Connectome Project (58), data from Hangzhou Normal University as part of the data provided by the Consortium for Reliability and Reproducibility (25), and the MICA-MICs dataset which is available on the Canadian Open Neuroscience Platform’s data portal. Human Connectome Project data was provided by the WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. We obtained GWAS summary statistics from the following consortia: Genetic Factors for Osteoporosis Consortium, Genetic Investigation of ANthropometric Traits, ICBP International Consortium for Blood Pressure, Diabetes Genetics Replication And Meta- analysis Consortium, Coronary Artery Disease Genome-wide Replication and Meta-analysis Consortium, Complex Traits Genetics Consortium, Social Science Genetic Association Consortium, International Multiple Sclerosis Genetics Consortium, International Parkinson Disease Genomics Consortium, Psychiatric Genomics Consortium. BMA GWAS summary statistics are available on the FUMA website (ID XXXX) [made public upon acceptance]